PARP1 and ischemia: Therefore, miR-124 could negatively regulate PARP1 to alleviate renal ischemia-reperfusion injury by inhibiting TNFα/RIP1/RIP3 pathway, miR-124 may be exploited as a novel therapeutic agent to attenuate IRI in renal acute injury and kidney transplantation.